As per notification buy back will start on or before Tuesday, March 21, 2023. So price may remain depressed few more days.
As per press release today (https://www.bseindia.com/xml-data/corpfiling/AttachLive/dc163688-74f3-4850-93e8-9201fb06decd.pdf)it announced the launch of
additional strengths for the generic version of Revlimid® (lenalidomide capsules), in 2.5
mg, and 20 mg strengths, in the United States, through its marketing partner Teva
Pharmaceuticals completing all strengths for revlimed in us market.
Disc: increased holding to 5% of PF. Holding at little higher costs than current market rate.
| Subscribe To Our Free Newsletter |
